Abstract
Sentinel lymph node (SLN) biopsy is a standard procedure for axillary staging among patients with clinically node-negative breast cancer. Both the radioisotope and blue dye methods are well established for SLN identification. The indocyanine green (ICG) fluorescence method reveals subcutaneous lymphatic flow and enables the surgeon to navigate and perform sequential dissection of SLNs. The ICG fluorescence method has an equal or higher SLN identification rate compared to conventional methods, and there was no significant difference in the detection of positive SLNs between the ICG fluorescence and radioisotope methods. Hence, the ICG fluorescence method is an acceptable alternative to conventional methods for SLN detection. However, the accuracy of the ICG fluorescence method after preoperative systemic therapy has not yet been systematically evaluated; therefore, long-term follow-up data about survival and adverse events after the application of the ICG fluorescence method are needed to confirm the clinical significance of this method. The recent technological innovation in SLN mapping enables physicians to perform real-time navigation surgery for SLN biopsy. Here, we introduce the technical details and current data of SLN biopsy using the ICG fluorescence method, and describe the technical innovation of SLN mapping.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(5):561–4.
Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106(1):4–16.
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33.
Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–53.
Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.
Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12(3):211–5.
Sugie T, Kinoshita T, Masuda N, Sawada T, Yamauchi A, Kuroi K, et al. Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 2016;23(1):44–50.
Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013;20(7):2213–8.
Wishart GC, Loh SW, Jones L, Benson JR. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol. 2012;38(8):651–6.
Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15(8):e351–e62.
Sugie T, Ikeda T, Kawaguchi A, Shimizu A, Toi M. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis. Int J Clin Oncol. 2017;22(1):11–7.
Tsuyuki S, Yamaguchi A, Kawata Y, Kawaguchi K. Assessing the effects of neoadjuvant chemotherapy on lymphatic pathways to sentinel lymph nodes in cases of breast cancer: usefulness of the indocyanine green-fluorescence method. Breast. 2015;24(3):298–301.
Takeuchi M, Sugie T, Abdelazeem K, Kato H, Shinkura N, Takada M, et al. Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer. Breast J. 2012;18(6):535–41.
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, et al. Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence. Breast Cancer. 2018;25:650.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Video of sentinel lymph node (SLN) biopsy using the medical imaging projection system (MIPS). Subcutaneous lymph channels (blue) visualized using the MIPS. Real-time fluorescence imaging helps to identify the fluorescent SLN after the skin incision is made. The ICG fluorescence signal visualized using a color scale indicating the strength of the signal (red = strong; yellow = medium; blue = weak). The projected fluorescence image is automatically adjusted upon deformation of the organ (MP4 150248 kb)
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Takada, M., Toi, M. (2020). Sentinel Lymph Node Mapping. In: Aleassa, E., El-Hayek, K. (eds) Video Atlas of Intraoperative Applications of Near Infrared Fluorescence Imaging. Springer, Cham. https://doi.org/10.1007/978-3-030-38092-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-030-38092-2_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-38091-5
Online ISBN: 978-3-030-38092-2
eBook Packages: MedicineMedicine (R0)